Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-008558
Filing Date
2025-03-18
Accepted
2025-03-18 21:30:09
Documents
1
Period of Report
2025-03-15

Document Format Files

Seq Description Document Type Size
1 form4-03182025_090306.html 4  
1 form4-03182025_090306.xml 4 16791
  Complete submission text file 0001415889-25-008558.txt   18261
Mailing Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BOULEVARD, SUITE 300 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Issuer) CIK: 0001759425 (see all company filings)

EIN.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MIRUM PHARMACEUTICALS, INC. 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address
Howe Jolanda (Reporting) CIK: 0001974200 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38981 | Film No.: 25750636